Work for Deciphera Pharmaceuticals, Inc.?

Claim Your Profile

Deciphera Pharmaceuticals, Inc. Logo Image

Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc. Banner Image

About Deciphera Pharmaceuticals, Inc.

201-500 Employees
Based in Waltham, Massachusetts

Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. They are leveraging their proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from their platform in clinical studies, QINLOCKTM is Deciphera’s FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Canada and Australia.

Ticker:
DCPH
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol